EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Dual Antithyroid Drug-Induced Agranulocytosis in Graves’ Disease With Decompensated Heart Failure: A Multidisciplinary Approach

Amarildo Voci iD, Liri Seraj iD, Mario Shehu, Asfloral Haxhiu

Clinical Medicine Insights: Case Reports · 2026-04 · 19

DOI: 10.1177/11795476261446355 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Medicine Insights: Case Reports, online erschienen am 27.04.2026. Verfasst von Amarildo Voci und 3 weiteren Autor:innen. Beteiligte Einrichtung: Regional Memorial Hospital, Fier, Albania. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antithyroid drug-induced agranulocytosis is a rare but potentially life-threatening complication, particularly in patients with limited therapeutic options. This case illustrates the complexity of managing uncontrolled thyrotoxicosis in the context of a patient with decompensated heart failure, chronic obstructive pulmonary disease (COPD), and adverse reactions to both methimazole and propylthiouracil. A 54-year-old male patient with a 2-year history of Graves’ disease presented with worsening dyspnea and tachycardia in the setting of thyrotoxicosis with a TSH of 0.0007 mIU/L. He had previously developed agranulocytosis (ANC 180 cells/µL) subsequent to treatment with methimazole, and subsequently developed febrile agranulocytosis (ANC 190 cells/µL) upon initiation of propylthiouracil, thereby exhausting all antithyroid drug options. A bridging therapy of Lugol’s iodine and granulocyte colony-stimulating factor (G-CSF) was utilized, which enabled successful total thyroidectomy. Right heart catheterization confirmed the patient’s suitability for surgery despite a left ventricular ejection fraction of 35%. This case highlights the importance of interdisciplinary collaboration in managing complex endocrine-cardiac-hematology presentations.

Schlagwörter

Stichwörter der Autor:innen

agranulocytosiscase reportheart failurepropylthiouracilthyroidectomy

Autor:innen und Institutionen

  • Regional Memorial Hospital, Fier, Albania.
  • Municipality Hospital of Lushnja, Albania.

ORCID-Profile: Amarildo Voci, Liri Seraj

Zitieren

APA

Voci, A., Seraj, L., Shehu, M., & Haxhiu, A. (2026). Dual Antithyroid Drug-Induced Agranulocytosis in Graves’ Disease With Decompensated Heart Failure: A Multidisciplinary Approach. Clinical Medicine Insights: Case Reports, 19. https://doi.org/10.1177/11795476261446355

Vancouver

Voci A, Seraj L, Shehu M, Haxhiu A. Dual Antithyroid Drug-Induced Agranulocytosis in Graves’ Disease With Decompensated Heart Failure: A Multidisciplinary Approach. Clinical Medicine Insights: Case Reports. 2026;19. doi:10.1177/11795476261446355

BibTeX
@article{Voci2026,
  author = {Voci, Amarildo and Seraj, Liri and Shehu, Mario and Haxhiu, Asfloral},
  title = {Dual Antithyroid Drug-Induced Agranulocytosis in Graves’ Disease With Decompensated Heart Failure: A Multidisciplinary Approach},
  journal = {Clinical Medicine Insights: Case Reports},
  year = {2026},
  volume = {19},
  doi = {10.1177/11795476261446355}
}
Kostenlos starten →